Nucleate
Вебинар MilliporeSigma 2: Основы продаж
Blackjack, Biosecurity and Big Bets | Alexander Titus, National Biotech Commissioner
Вебинар MilliporeSigma 1: За пределами академической среды: построение успешной карьеры после пол...
Серия вебинаров Nucleate Arizona Genesis Spotlight — Джойс Канефски
Nucleate Arizona Genesis Spotlight Webinar Series - David Giltner
Nucleate Arizona Genesis Spotlight Webinar Series - Donald Munroe
The Science of Saving Millions | Mikael Dolsten, Fmr. CSO of Pfizer
What it Takes to Build a $50B Biotech Moonshot | John Maraganore, Founding CEO of Alnylam
2025 Nucleate Summit Recap
Activator Alumni Panel: Jonathan Rittichier & Chelsea Trengrove
Alnylam BioVenture Challenge Highlight: Claire Zeng
Heartbreak to Hope: A Mother’s Mission to Cure Angelman Syndrome | Dr Allyson Berent, CSO of FAST
Nucleate Virtual Summit: Congressman Jake Auchnincloss on Policy & the Future of Biotech
Fedsprout Webinar 6: How to Write a Competitive DoD SBIR/STTR Phase I Proposal
Alnylam BioVenture Challenge 2025 Info Session Highlight: Demetri Maxim
Nucleate Virtual Summit: The Long Fight for Equity in Science
Nucleate Virtual Summit: Nucleate Leadership Alumni - Where Are They Now?
Nucleate Virtual Summit: Genetic Editing at a Crossroads
Nucleate Virtual Summit: Activator Alumni Shaping the Future of Biotech
Nucleate Virtual Summit 2025: George Church on Building Biotech Companies
Decoding the Future: Data, AI, and Biotech with Joe Horsman | Joe Horsman, Investor at Madrona VC
Student to Startup: Dr. David Snow’s Road to Leading Texas Innovation | Nucleate Alumni Summit 2025
When board turns, but mission stays | Armon Sharei, Founder & CEO at Portal on Resilience in Biotech
Workshop 5: DoD SBIR/STTR 101: Non-Dilutive Capital for Life Science Spinouts
The 10% mindset and power of bold ideas | Dominik Ruettinger, Global Head Oncology R&D, Bayer
Fedsprout Workshop 4: Writing a Winning NIH SBIR/STTR Proposal
Fedsprout Workshop 3: NIH SBIR/STTR 101: A Guide for Applicants at All Levels
Startups are hard, do something that matters | Armand Cognetta, CEO & founder General Proximity
Nucleate Germany Demo Day 2025